BR0010615A - Aril-cloro-etil-uréias inovadoras - Google Patents

Aril-cloro-etil-uréias inovadoras

Info

Publication number
BR0010615A
BR0010615A BR0010615-1A BR0010615A BR0010615A BR 0010615 A BR0010615 A BR 0010615A BR 0010615 A BR0010615 A BR 0010615A BR 0010615 A BR0010615 A BR 0010615A
Authority
BR
Brazil
Prior art keywords
alkyl
halide
derivatives
cycloalkyl
alkoxy
Prior art date
Application number
BR0010615-1A
Other languages
English (en)
Inventor
Rene C Gaudreault
Original Assignee
Univ Laval
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Laval filed Critical Univ Laval
Publication of BR0010615A publication Critical patent/BR0010615A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C07C275/34Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"ARIL-CLORO-ETIL-URéIAS INOVADORAS". Descreve-se na presente invenção derivados inovadores de 1aril-3-(2-cloro-etil)-uréias. Esses derivados são agentes anticancerígenos úteis, tendo excelente especificidade para células-alvo e potente atividade antineoplásica, sem toxicidade sistêmica ou mutagenicidade. Mais especificamente, a invenção refere-se a derivados inovadores da fórmula (I), onde R~ 1~, é alquila inferior de C~ 1~-C~ 6~, ciclo-alquila C~ 3~-C~ 7~, alcóxi inferior de C~ 1~-C~ 6~, hidróxi-alquila inferior de C~ 1~-C~ 6~, ou halogeneto inferior de C~ 1~-C~ 6~; R~ 2~ é H, alquila inferior de C~ 1~-C~ 6~, ciclo-alquila C~ 3~-C~ 7~, alcóxi inferior de C~ 1~-C~ 6~, hidróxialquila inferior de C~ 1~-C~ 6~, ou halogeneto, di-halogeneto ou tri-halogeneto inferiores de C~ 1~-C~ 6~, R~ 1~ e R~ 2~ poderiam ser também parte de estruturas cíclicas expressas pela fórmula (II); R~ 3~ e R~ 4~ são como definido em R~ 5~, ou halogeneto, di-halogeneto, tri-halogeneto, dialquila inferior de C~ 1~-C~ 7~, ou grupos alicíclicos com a estrutura (III), onde n = 2 a 8 átomos de carbono, sendo que o dito anel alicíclico pode ser também substituído com um ou mais grupos como definido em R~ 5~; ou anéis policíclicos que possuem não mais do que três anéis, onde os anéis, que não o anel que possui o grupamento 2-cloroetil-amino substituído, podem ser substituídos com um ou mais grupos como os definidos em R~ 5~; R~ 5~ é H, alquila inferior de C~ 1~-C~ 7~, alcóxi inferior de C~ 1~-C~ 7~, hidróxi-alquila de C~ 1~-C~ 7~, amino-alquila de C~ 1~-C~ 7~, tioalquila de C~ 1~-C~ 6~, S-alquila inferior de C~ 1~-C~ 5~, N-alquila inferior de C~ 1~-C~ 7~, N,N-dialquila inferior de C~ 1~-C~ 7~, ciano-alquila inferior de C~ 1~-C~ 9~, halo-alquila inferior de C~ 1~-C~ 7~, sulfóxido inferior de C~ 1~-C~ 7~, ou ciclo-alquila de C~ 3~-C~ 7~; ou um seu pró-medicamento. Descrevese também composições farmacêuticas que contêm os compostos da invenção em conjunto com um veículo de uso farmacêutico, e o uso das composições no tratamento de câncer.
BR0010615-1A 1999-04-12 2000-04-12 Aril-cloro-etil-uréias inovadoras BR0010615A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002268588A CA2268588A1 (en) 1999-04-12 1999-04-12 Novel aryl-chloro-ethyl ureas
PCT/CA2000/000413 WO2000061546A2 (en) 1999-04-12 2000-04-12 Novel aryl-chloro-ethyl ureas

Publications (1)

Publication Number Publication Date
BR0010615A true BR0010615A (pt) 2003-07-22

Family

ID=4163454

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0010615-1A BR0010615A (pt) 1999-04-12 2000-04-12 Aril-cloro-etil-uréias inovadoras

Country Status (10)

Country Link
US (1) US6686394B1 (pt)
EP (1) EP1169303B1 (pt)
JP (1) JP2002541240A (pt)
AT (1) ATE312075T1 (pt)
AU (1) AU778391B2 (pt)
BR (1) BR0010615A (pt)
CA (1) CA2268588A1 (pt)
DE (1) DE60028563T2 (pt)
MX (1) MXPA01010311A (pt)
WO (1) WO2000061546A2 (pt)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61191667A (ja) 1985-02-21 1986-08-26 Tokuyama Soda Co Ltd 尿素化合物
CA2116621C (en) * 1993-03-03 2001-07-24 Rene C. Gaudreault Novel anticancer agents
US5750547A (en) 1995-01-06 1998-05-12 Universite Laval Certain carbanate anti-cancer agents

Also Published As

Publication number Publication date
JP2002541240A (ja) 2002-12-03
DE60028563D1 (de) 2006-07-20
CA2268588A1 (en) 2000-10-12
ATE312075T1 (de) 2005-12-15
DE60028563T2 (de) 2006-11-09
WO2000061546A3 (en) 2001-01-11
MXPA01010311A (es) 2005-09-08
AU3952000A (en) 2000-11-14
AU778391B2 (en) 2004-12-02
WO2000061546A2 (en) 2000-10-19
US6686394B1 (en) 2004-02-03
EP1169303B1 (en) 2005-12-07
EP1169303A2 (en) 2002-01-09

Similar Documents

Publication Publication Date Title
WO2004085421A3 (en) Bioreductively-activated prodrugs
WO2008114819A1 (ja) 新規アデニン化合物
WO2002000650A3 (en) Novel compounds possessing antibacterial, antifungal or antitumor activity
TW200612920A (en) Novel imidazolidine derivatives
HUP0101793A2 (hu) Antranilsav-származékok, mint cGMP-foszfodiészteráz gátlók
ATE356117T1 (de) Derivate des n-((chinolinyl)oxy)-phenyl)- harnstoffs und des n-((chinazolinyl)oxy)-phenyl)- harnstoffs mit antitumor aktivität
ID29452A (id) 4-okso-1,4-dihidro-3-quinolinkarboksamida sebagai agen-agen antivirus
CR8755A (es) Derivado de quinolina fusionada y uso del mismo
NZ512658A (en) Heterocyclic-substituted diphenylurea derivatives and pharmaceutical compositions containing them
CA2493995A1 (en) Macrolide compounds endowed with antiinflammatory activity
TW200732284A (en) Amine compound and pharmaceutical use thereof
TNSN07357A1 (en) Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same
DK1468692T3 (da) Anvendelse af 2,6-di-alkyl-4-silyl-phenoler til behandling af xantom
DE60105610D1 (en) Pyrazinonderivate
BR0010615A (pt) Aril-cloro-etil-uréias inovadoras
NO20053302D0 (no) Imidazolderivater med affinitet for alfa 2-reseptoraktivitet.
GB9812211D0 (en) Cinnamoyl distamycin analogous derivatives,process for their preparation,and their use as antitumor agents
PL359460A1 (en) Carbamate and thiocarbamate podophyllotoxin derivatives, preparation method and pharmaceutical compositions containing them
RS51051B (sr) Heksaciklična jedinjenja
SE1069132T3 (sv) Bicykliska derivate av amino-pyrazinoner, foerfarande foer framstaellning och farmaceutiska kompositioner innehallande dem
MXPA04000615A (es) Compuestos utiles para el tratamiento o la prevencion de enfermedades mediadas por alfa-2b-adrenoceptor.
TW200510300A (en) Amino alcohol compounds
DE69714709D1 (de) Cyclische amic-säurederivate
ES2058182T3 (es) Analogos de mitomicina. un procedimiento para su preparacion y composiciones farmaceuticas.
DK0410224T3 (da) Pyrrolo(2,1-b)thiazol-derivater

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: SOVAR, SOCIETE EN COMMANDITE (CA)

Free format text: TRANSFERIDO DE: UNIVERSITE LAVAL

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 NA RPI2003 DE 26/05/2009.